Afuco™ Anti-Human GM2 ADCC Therapeutic Antibody (BIW-8962), ADCC Enhanced
Anti-GM2 ADCC Enhanced Antibody (BIW-8962) is an ADCC enhanced antibody produced by our Afuco™ platform. BIW-8962 is a humanized anti-ganglioside GM2 (GM2) monoclonal antibody, exhibited a potent ADCC and less potent CDC activity. Currently BIW-8962 is being investigated in a Phase 1 study in patients with multiple myeloma.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-307CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | GM2 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at -20°C. Open under aseptic conditions. |